Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEEnergyOil & Gas MidstreamSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.21 → 3.20 EPS · FY ending Dec 31, 2027 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for ENB yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA between $20.2B and $20.8B and DCF per share between $5.70 and $6.10 in 2026 | Enbridge delivers adjusted EBITDA near $20.8 billion and DCF per share around $6.10 in 2026. | Intact | Adjusted EBITDA or DCF per share falls below $20.2B or $5.70 respectively in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a mature energy infrastructure business with a project-led growth case, rather than a turnaround or high-growth story. The long-term thesis is intact, and the latest signal is mildly favorable, but confidence in the evidence snapshot is low.
The valuation evidence suggests ENB is cheap versus peers, while the overall value assessment is neutral. The snapshot does not specify the market’s exact growth or earnings assumptions; it points to a turbulent sector setting, but not a combination of expensive valuation, weak fundamentals, and turbulence.
Near term, results are tracking management’s 2026 guidance, which was reaffirmed, and the secured growth backlog expanded as major projects advanced. Debt management is mixed: the debt-to-EBITDA ratio is near management’s target range but rose from 5.0x to 5.1x in the first half of 2026. A guidance cut would be a meaningful warning, although the stated near-term miss risk is low.
Over the next year, the thesis depends on ENB continuing to deliver its 2026 financial guidance and execute its backlog. Sector conditions are another swing factor: continued strong results and higher guidance from WMB, KMI, and ET would support the energy-sector tailwind, while weaker results or guidance could weaken it. The snapshot gives limited detail on the CEO transition’s implications.
For a 1-to-3-year view, ENB’s operating and project evidence remains supportive, but debt discipline and sector conditions need watching. The evidence is low confidence, so the thesis is intact rather than proven. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 2 supplied quarters. Management reported: “FINANCIAL OUTLOOK The Company reaffirms its 2026 financial guidance for adjusted EBITDA between $20.2 billion and $20.8 billion and DCF per share between $5.70 and $6.10.” “The Company also reaffirms its post-2026 adjusted EBITDA, DCF per share, and EPS near-term average compound annual growth rate of approximately 5%.”
Maintain disciplined capital allocation including $2B senior notes issuance in 2026-Q1 | Capital allocation discipline is strong with $2 billion senior notes issued to support flexibility. | Intact | Failure to complete $2B senior notes issuance in 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 2 supplied quarters. Management reported: “The Company is committed to maintaining its financial strength and continues to target leverage of 4.5x to 5.0x Debt-to-Adjusted EBITDA while retaining strong investment grade credit ratings.” “FINANCING UPDATE The Company's rolling 12-month Debt-to-EBITDA metric at the end of the second quarter of 2026 was 5.1x, elevated in part due to the period end debt balance translating at a 1.42 CAD/USD foreign exchange rate compared to EBITDA translating at an average trailing 12-month rate of 1.38.” Delivery assessment Nov 4, 2026 |
Quarterly dividend per share around $0.97 | The company maintains steady dividend payments near $0.97 per share quarterly. | Broken | Dividend per share falls below $0.97 in any quarter | Required source inputs unavailable Cannot calculate Dividend per share from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.19 → $3.20 · observed estimates
$68.78B → $72.68B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.19 | $68,779,971,690 | 17 / 6 |
| 2026-07-25 | $3.19 | $68,779,971,690 | 17 / 6 |
| 2026-07-26 | $3.19 | $68,683,766,019 | 16 / 5 |
| 2026-07-27 | $3.18 | $64,689,427,716 | 10 / 5 |
| 2026-07-28 | $3.18 | $64,689,427,716 | 10 / 5 |
| 2026-07-29 | $3.18 | $64,552,759,911 | 10 / 5 |
| 2026-07-30 | $3.19 | $68,683,766,019 | 16 / 5 |
| 2026-07-31 | $3.18 | $68,683,766,019 | 16 / 5 |
| 2026-08-01 | $3.21 | $64,980,985,700 | 9 / 5 |
| 2026-08-02 | $3.27 | $72,435,560,640 | 16 / 6 |
| 2026-08-03 | $3.29 | $68,222,737,255 | 10 / 5 |
| 2026-08-04 | $3.27 | $72,435,560,640 | 16 / 6 |
| 2026-08-05 | $3.29 | $68,222,737,255 | 10 / 5 |
| 2026-08-06 | $3.22 | $74,694,952,030 | 18 / 7 |
| 2026-08-07 | $3.29 | $68,222,737,255 | 10 / 5 |
| 2026-08-08 | $3.22 | $74,694,952,030 | 18 / 7 |
| 2026-08-09 | $3.22 | $74,694,952,030 | 18 / 7 |
| 2026-08-10 | $3.29 | $68,222,737,255 | 10 / 5 |
| 2026-08-11 | $3.29 | $68,222,737,255 | 10 / 5 |
| 2026-08-12 | $3.22 | $74,694,952,030 | 18 / 7 |
| 2026-08-13 | $3.29 | $68,222,737,255 | 10 / 5 |
| 2026-08-14 | $3.29 | $68,222,737,255 | 10 / 5 |
| 2026-08-15 | $3.29 | $68,222,737,255 | 10 / 6 |
| 2026-08-16 | $3.29 | $68,222,737,255 | 10 / 6 |
| 2026-08-17 | $3.29 | $68,222,737,255 | 10 / 6 |
| 2026-08-18 | $3.29 | $68,222,737,255 | 10 / 6 |
| 2026-08-19 | $3.29 | $68,222,737,255 | 10 / 6 |
| 2026-08-20 | $3.29 | $70,015,077,701 | 10 / 6 |
| 2026-08-21 | $3.31 | $70,453,097,790 | 10 / 6 |
| 2026-08-22 | $3.31 | $70,569,903,147 | 10 / 6 |
| 2026-08-23 | $3.31 | $70,569,903,147 | 10 / 6 |
| 2026-08-24 | $3.32 | $70,676,974,724 | 10 / 6 |
| 2026-08-25 | $3.30 | $70,277,889,754 | 10 / 6 |
| 2026-08-26 | $3.30 | $70,277,889,754 | 10 / 6 |
| 2026-08-27 | $3.30 | $70,277,889,754 | 10 / 6 |
| 2026-08-28 | $3.30 | $70,277,889,754 | 10 / 6 |
| 2026-08-29 | $3.29 | $70,219,487,076 | 10 / 6 |
| 2026-08-30 | $3.29 | $70,219,487,076 | 10 / 6 |
| 2026-08-31 | $3.29 | $70,219,487,076 | 10 / 6 |
| 2026-09-01 | $3.28 | $69,966,408,802 | 10 / 6 |
| 2026-09-02 | $3.29 | $70,219,487,076 | 10 / 6 |
| 2026-09-03 | $3.29 | $70,277,889,754 | 11 / 6 |
| 2026-09-04 | $3.30 | $70,501,766,688 | 11 / 6 |
| 2026-09-05 | $3.30 | $70,501,766,688 | 9 / 6 |
| 2026-09-06 | $3.30 | $70,501,766,688 | 9 / 6 |
| 2026-09-07 | $3.29 | $70,297,357,314 | 9 / 6 |
| 2026-09-08 | $3.29 | $70,297,357,314 | 9 / 6 |
| 2026-09-09 | $3.30 | $70,423,896,450 | 9 / 6 |
| 2026-09-10 | $3.31 | $70,658,720,976 | 9 / 6 |
| 2026-09-11 | $3.29 | $71,334,613,665 | 9 / 5 |
| 2026-09-12 | $3.31 | $68,061,565,441 | 9 / 5 |
| 2026-09-13 | $3.31 | $68,061,565,441 | 8 / 5 |
| 2026-09-14 | $3.31 | $68,061,565,441 | 8 / 5 |
| 2026-09-15 | $3.30 | $68,505,564,780 | 8 / 5 |
| 2026-09-16 | $3.30 | $70,867,539,476 | 7 / 5 |
| 2026-09-17 | $3.29 | $70,736,580,021 | 7 / 4 |
| 2026-09-18 | $3.29 | $70,736,580,021 | 7 / 4 |
| 2026-09-19 | $3.29 | $70,736,580,021 | 7 / 4 |
| 2026-09-20 | $3.28 | $70,372,060,040 | 6 / 3 |
| 2026-09-21 | $3.23 | $69,467,574,301 | 6 / 3 |
| 2026-09-22 | $3.23 | $69,453,700,804 | 6 / 3 |
| 2026-09-23 | $3.25 | $69,464,703,009 | 7 / 3 |
| 2026-09-24 | $3.25 | $69,464,703,009 | 7 / 3 |
| 2026-09-25 | $3.24 | $69,324,876,277 | 6 / 3 |
| 2026-09-26 | $3.24 | $69,321,629,818 | 6 / 3 |
| 2026-09-27 | $3.24 | $69,321,629,818 | 6 / 3 |
| 2026-09-28 | $3.26 | $69,629,649,872 | 6 / 3 |
| 2026-09-29 | $3.26 | $69,771,522,956 | 6 / 3 |
| 2026-09-30 | $3.26 | $69,771,522,956 | 6 / 3 |
| 2026-10-01 | $3.25 | $71,718,786,743 | 6 / 4 |
| 2026-10-02 | $3.24 | $71,496,696,051 | 7 / 5 |
| 2026-10-03 | $3.21 | $71,380,496,068 | 8 / 5 |
| 2026-10-04 | $3.21 | $71,380,496,068 | 8 / 5 |
| 2026-10-05 | $3.21 | $71,444,296,156 | 8 / 5 |
| 2026-10-06 | $3.21 | $71,312,142,506 | 8 / 5 |
| 2026-10-07 | $3.20 | $71,281,645,510 | 8 / 5 |
| 2026-10-08 | $3.18 | $71,515,455,814 | 8 / 5 |
| 2026-10-09 | $3.17 | $71,261,314,180 | 8 / 5 |
| 2026-10-10 | $3.17 | $71,261,314,180 | 8 / 5 |
| 2026-10-11 | $3.18 | $71,413,799,160 | 8 / 5 |
| 2026-10-12 | $3.18 | $71,465,389,742 | 8 / 5 |
| 2026-10-13 | $3.18 | $71,370,854,103 | 8 / 5 |
| 2026-10-14 | $3.17 | $71,049,735,798 | 8 / 5 |
| 2026-10-15 | $3.18 | $71,454,085,390 | 8 / 5 |
| 2026-10-16 | $3.18 | $71,436,791,829 | 8 / 6 |
| 2026-10-17 | $3.18 | $71,436,791,829 | 8 / 6 |
| 2026-10-18 | $3.18 | $71,691,196,358 | 8 / 5 |
| 2026-10-19 | $3.18 | $71,691,196,358 | 8 / 5 |
| 2026-10-20 | $3.19 | $71,884,849,601 | 8 / 5 |
| 2026-10-21 | $3.20 | $72,037,406,582 | 8 / 5 |
| 2026-10-22 | $3.21 | $72,271,327,287 | 8 / 5 |
| 2026-10-23 | $3.20 | $72,566,270,784 | 8 / 5 |
| 2026-10-24 | $3.19 | $72,566,270,784 | 8 / 4 |
| 2026-10-25 | $3.19 | $72,566,270,784 | 8 / 4 |
| 2026-10-26 | $3.19 | $72,586,611,715 | 8 / 4 |
| 2026-10-27 | $3.19 | $72,586,611,715 | 8 / 4 |
| 2026-10-28 | $3.19 | $72,535,759,388 | 8 / 4 |
| 2026-10-29 | $3.18 | $72,352,691,011 | 7 / 3 |
| 2026-10-30 | $3.20 | $72,637,464,042 | 7 / 3 |
| 2026-10-31 | $3.20 | $72,647,634,508 | 7 / 3 |
| 2026-11-01 | $3.20 | $72,647,634,508 | 7 / 3 |
| 2026-11-02 | $3.20 | $72,647,634,508 | 7 / 3 |
| 2026-11-03 | $3.20 | $72,739,168,697 | 7 / 3 |
| 2026-11-04 | $3.20 | $72,678,145,904 | 7 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 14 Buy / Strong Buy · 9 Hold · 1 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 6, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.